Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Dow
Colorcon
McKesson
Moodys
AstraZeneca
Express Scripts

Last Updated: December 12, 2019

DrugPatentWatch Database Preview

COLESTID Drug Profile

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

When do Colestid patents expire, and when can generic versions of Colestid launch?

Colestid is a drug marketed by Pharmacia Upjohn and is included in two NDAs.

The generic ingredient in COLESTID is colestipol hydrochloride. There are two drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the colestipol hydrochloride profile page.

US ANDA Litigation and Generic Entry Outlook for Colestid

A generic version of COLESTID was launched as colestipol hydrochloride by IMPAX LABS on December 12th, 2019.

Drug patent expirations by year for COLESTID
Drug Prices for COLESTID

See drug prices for COLESTID

Recent Clinical Trials for COLESTID

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
National Heart, Lung, and Blood Institute (NHLBI)Phase 3
University of WashingtonPhase 3

See all COLESTID clinical trials

Pharmacology for COLESTID
Synonyms for COLESTID
37296-80-3
AC1MJ2ZS
C11H28ClN5O.HCl
C60H114O8.HCl
Colestipol HCl
Colestipol hydrochloride
Colestipol hydrochloride [USAN:USP]
Colestipol hydrochloride [USAN]
Copolymer of diethylenetriamine and 1-chloro-2,3-epoxypropane, hydrochloride (with approximately 1 out of 5 amine nitrogens protonated)
DTXSID40190737
Flavored Colestid
FT-0749664
GACQNVJDWUAPFY-UHFFFAOYSA-N
Lestid
LS-54700
N'-[2-[2-(2-aminoethylamino)ethylamino]ethyl]ethane-1,2-diamine hydrochloride
SCHEMBL284758
tetraethylenepentamine HCl
U-26597A
UNII-X7D10K905G
X7D10K905G

US Patents and Regulatory Information for COLESTID

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pharmacia Upjohn COLESTID colestipol hydrochloride GRANULE;ORAL 017563-003 Sep 22, 1995 AB RX Yes No   Start Trial   Start Trial   Start Trial
Pharmacia Upjohn COLESTID colestipol hydrochloride GRANULE;ORAL 017563-004 Sep 22, 1995 AB RX Yes Yes   Start Trial   Start Trial   Start Trial
Pharmacia Upjohn COLESTID colestipol hydrochloride TABLET;ORAL 020222-001 Jul 19, 1994 AB RX Yes Yes   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
Harvard Business School
Mallinckrodt
McKesson
McKinsey
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.